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ABSTRACT 
The identification of a regulatory mutation in the intron 3 of Insulin like growth factor 2, was a 
major finding. This single nucleotide mutation in the non coding region abrogates the interaction 
of nuclear factor ZBED6, resulting in the 3-4% increase in the muscle mass of domesticated pigs. 
The mutation was observed in the evolutionary conserved CpG island that is hypomethylated in 
skeletal muscle. ZBED6 has been derived from a domesticated DNA transposon exclusively 
present in the placental mammals. Chromatin immuno precipitation (ChIP) sequencing in mouse 
C2C12 myoblasts using anti-ZBED6 antibody identified 2499 ZBED6 binding fragments. The de 
novo search on the binding fragments of ZBED6 showed the consensus sequence of 5´-GCTCG-
3´. ZBED6 binding fragments contain more than 1200 genes with annotated functions in 
biological processes, transcriptional regulation, neurogenesis, cell signaling and muscle 
development. In present study we have done bioinformatics analysis on the ZBED6 using 
TRANSFAC database professional version 2010.1 in order to identify the other transcription 
factors co-regulating the expression of ZBED6 target genes. The ChIP data (ZBED6 target genes) 
and microarray expression data (siRNA silenced ZBED6) in mouse C2C12 cells were used in this 
study for finding the binding sites for transcription factors in the promoter regions. The genes 
associated with ZBED6 showed significant overrepresentation of binding sites of transcription 
factors SP1, ZF5, E2F1, ZBED6, AP2alpha and KROX in their promoter regions. Majority of 
factors found have GC rich binding sites and belongs to zinc finger families. The obtained factors 
show role in tumor suppression. The microarray expression data analysis showed that MEF2 and 
SRF transcription factors binding sites are significantly present in the promoters of co-expressed 
genes. The ZBED6 binding sites that were at a distance of 500 kb away from known transcription 
start site TSS, showed OCT1 and IRF1 binding sites. There is a possibility that these factors are 
the enhancer elements for many ZBED6 target genes. Few long non-coding RNAs were also 
identified in the vicinity of ZBED6 binding sites present at a distance of 500 kb away from known 
TSS. 
 
INTRODUCTION  
 
Muscle development in domesticated mammals 
The characteristics of meat (with low fat contents and high muscle fiber) are equally important in 
the production of meat and the consumer favor the lean and tender meat. The muscle development 
is identified in many species of domesticated mammals (e.g. cattle, sheep, pig and chicken). The 
pig is used for meat production throughout the world except for most Muslim countries. The 
history of pig domestication dates back at ~9000 years ago in the Near East and analyses of 
mitochondrial sequence showed that it occurred at multiple locations throughout Europe and Asia 
(Giuffra et al., 2000).  The ancestor of domesticated pigs is European wild boar (Sus scrofa) 
(Larson et al., 2005). The selection on lean meat during the last 60 years in domestic pigs resulted 
in increased muscle mass and low fat content (Markljung et al., 2009). Present day, breeds like 
Large White, Duroc, Landrace, Pietrain and Hampshire are used to produce the lean meat with the 
characteristics in terms of tenderness, leanness and moisture (Chen et al., 2007). As a result of this 
selection, the pig breeds with favorable muscle growth allele variants have increased with a 
concomitant reduced frequency of fat content allele variants. Genetic studies aimed at identifying 
loci influencing muscle growth have identified new genes and factors that might be involved in 
the regulation of muscle development and differentiation process.  
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Three different genes have been identified to have mutations affecting muscle growth; these 
include missense mutaion in the PRKAG3 gene that plays a key role in the regulation of energy 
metabolism in skeletal muscle, mutation in ryanodine receptor gene RYR1 that causes the 
malignant hyperthermia, which is a recessive disorder. This gene encodes the ryanodine receptor 
found in skeletal muscle. Furthermore, a single nucleotide substitution in the insulin-like growth 
factor 2 (IGF2) gene that is affecting the postnatal muscle growth (Milan et al., 2000; Fujii et al., 
1991; Van Laere et al., 2003).  
 
IGFs in muscle development 
The muscle growth and development of meat in animals is a complex and highly regulated 
process. The insulin-like growth factors IGFs i.e. IGF1 and IGF2 are strong regulators of cellular 
and tissue growth. As the control of muscle growth is at the molecular, cellular and tissue level, it 
is critically important to understand role of IGFs in muscle development. IGFs are structurally 
similar polypeptides with diverse biological functions and properties. IGFs function in both 
endocrine and paracrine processes (Oksbjerg et al., 2004; Kokta et al., 2004). Both IGF1 and 
1GF2 show great role in the proliferation and differentiation of muscle cells (Oksbjerg et al., 
2004). IGF1 has been identified to be important in both proliferation and differentiation of 
myoblasts (Engert et al., 1996). Similarly, it has been observed that IGF2 is important for the 
transition from proliferation to differentiation of myoblasts (Florini et al., 1991).  
 
Different in vivo knockdown mice studies showed great importance of IGF1 and IGF2 as it 
reduces the number of cells in different tissues including muscle cells (Liu et al., 1993).  The 
expression level of IGF2 mRNA increases and reaches maximum expression level at the stage of 
myogenesis in growing muscle fibers whereas the level of IGF1 mRNA expression increases 
slightly at initial stages but in neonatal pigs it increases at maximum point (Gerrard et al., 1998).  
The growth hormone (GH) stimulates these factors (Oksbjerg et al., 2004).  The IGFs interacts 
with three different receptors i.e. IGF1R, IGF2R and insulin receptor. The IGF1 can bind with 
IGF1R and insulin receptor while IGF2 can bind with IGF1R and IGF2R with different binding 
affinities. IGF1 is the natural activator of AKT signaling pathway and inhibitor of programmed 
cell death. The signaling pathways that mediate the effects of IGFs in the muscle cells are 
Phosphatidylinositol-3-kinase (PI3K) pathway and mitogen activated protein kinase (MAPK) 
pathway. It has been defined that IGF1-induced MAPK pathway is mainly involved in 
proliferation while PI3K pathway is involved in cell differentiation (Coolican et al., 1997). On the 
other hand, IGF2 has been shown to induce differentiation through PI3K pathway (Kaliman et al., 
1999). The biological activities of these factors are greatly regulated by the family of IGF binding 
proteins (IGFBPs). These vertebrate IGFBPs belong to a group of secreted proteins that binds to 
IGF1 and IGF2 and control their actions. Both circulating and locally expressed IGF1 has been 
shown to be involved in postnatal muscle growth in many studies (Oksbjerg et al., 2004). Not 
many studies indicate the effect of IGF2 on the postnatal muscle growth although some indicate 
its effect on the fat deposition (Owens et al., 1999).  Due to a point mutation in the regulatory 
region of the IGF2 gene, an increase in skeletal muscle-specific IGF2 mRNA expression in pig 
muscle that increased the muscle mass by 3-4% in postnatal pigs (Van Laere et al., 2003). 
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Gene Regulation 
All the cells have same set of genes but only few genes are expressed in each cell type, this is 
controlled by the regulatory sequences which are present in the non protein coding regions where 
the regulatory proteins binds. The structure of chromosomes i.e. the chromatin determines the fate 
of the transcription mainly through the DNA methylation and various histone modifications. Cis-
acting gene regulatory regions control the expression of genes in space, time and quantity. These 
include 
• Promoter regions (core promoter, upstream promoter and regulatory promoter) 
• Enhancer regions (binds repressors and activators) 
Changes in chromatin structure (epigenetic modifications) at regulatory regions involve histone 
acetylation and histone methylation and on DNA, (CpG) methylation that can lead to the 
activation or deactivation of certain transcriptional processes at different time and place. For gene 
expression the regulatory sequence must be accessible to the RNA polymerases and other 
transcription factors. 
 
Regulatory Mutation in IGF2 
Regulatory mutations influence transcription and occur in the regulatory regions (promoters or 
enhancers) of the genes. The mutations may influence binding of the regulatory transcription 
factors and preventing their binding to that regulatory region. Quantitative Trait Locus (QTL) 
mapping is the study of Quantitative Traits (a complex trait that can be measured or continuous 
trait e.g. body weight) that is affected by the genotype and environment. The objective of QTL 
mapping study is to identify a region or regions in the genome that are associated with some 
particular complex trait including a complex disease. Ultimately, detailed fine-mapping and re-
sequencing may allow the identification of causative mutation(s) for the QTL. 
 
A paternally expressed imprinted QTL that is affecting the skeletal and cardiac muscle growth and 
fat deposition was first identified in a study using an intercross between the European wild boar 
with large white domestic pigs and also Pietrain with large white pigs and the imprinted QTL 
mapped to the IGF2 locus in pigs  (Jeon et al., 1999; Nezer et al., 1999). This intercross allowed 
QTL mapping of genes influencing increased muscle mass and reduced fat deposition. In a 
subsequent follow-up study, the haplotype sharing approach was used and it was found that the 
favorable alleles had gone through a selective sweep as a result of strong selection for lean meat. 
A single nucleotide point mutation denoted Q was identified in the QTL bearing region, this 
mutation was not present in the wild type allele q (within the 250 kb interval between the markers 
370SNP6/15 and SWC9) where this region contain the IGF2 and INS genes. The IGF2 gene was 
identified as an excellent candidate gene because it is paternally expressed (Van Laere et al., 
2003). The IGF2 gene was resequenced from multiple q and Q haplotypes and the mutated Q 
haplotype was shown to harbor a transition mutation Guanine to Adenine (G to A) in intron 3 at 
nucleotide 3072, which is the causative Quantitative trait nucleotide QTN (Van Laere et al., 
2003). This QTN is located in an evolutionary conserved CpG island located between 
differentially methylated region 1 DMR1 and matrix attachment region (Amarger et al., 2002; 
Greally et al., 1997; Eden et al., 2001). IGF2 was also well-known to have critical and important 
function during myogenesis (Florini et al., 1995). 
 
A region of 94 bp around the point mutation in IGF2 intron 3 (Fig. 1) at the nucleotide 3072 is 
highly conserved (85 % sequence identity having 8bp palindrome upstream of the QTN) among 
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eight species of mammals i.e. rat, mouse, human, rabbit, dog, horse, bovine and pig (with wild 
type q and mutant type Q). It also shows the other genes INS and TH along with IGF2 within the 
28.6 kb with sequence similarity within the pigs. The CpG island was found to be non-methylated 
at a region centered at the QTN in case of skeletal muscles while in case of liver it was methylated 
(Van Laere at al., 2003).  
 
 
Figure 1. The QTN in IGF2 intron 3 is highly conserved (Yellow star shows the position of point 
mutation) Van Laere et al., 2003 
 
The biochemical and functional analyses of this mutation was performed using Electrophoretic 
mobility shift assay (EMSA) with double-stranded oligonucleotides corresponding to either wild 
type q or mutant type Q sequence. These oligonucleotides were incubated with nuclear extracts 
prepared from murine C2C12 myoblast cells. The study showed that the wild type q binds to a 
nuclear factor when it is unmethylated but cannot bind when it has mutation or methylation at the 
CpG dinucleotide at the QTN. Functional studies were performed using transient transfection 
assays using reporters driving the expression of Luciferase to determine the effect of mutation on 
IGF2 transcription in myoblast C2C12 cells. Reporter constructs harboring either mutant Q or 
wild type q regions inserted upstream of the IGF2 P3 promoter were constructed and used to 
transfect C2C12 cells. A significant increase in transcriptional activity was observed using 
reporter constructs with the mutant Q versus the wild type q allele. These results confirms that the 
wild type q sequence interacts with a repressor of IGF2 transcription in C2C12 myoblast (Van 
Laere et al., 2003) 
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ZBED6 controlling IGF2 expression 
In order to identify the repressor of IGF2, the murine C2C12 myoblast cells were used and the 
Oligonucleotide capture and Mass Spectrometry experiments were done (Markljung et al., 2009). 
Two different types of nuclear extracts were made from the C2C12 cells using the stable isotope 
labeling of amino acids (lysine and arginine) in culture SILAC (Ong et al., 2008). The results 
showed the highest-fold enrichment of repressor protein (wild type q) with the previously 
undefined alternative splice variant of zc3h11a gene. The repressor was named as ZBED6.  
 
The regulatory mutation (G to A transition) in intron 3 of IGF2 leads to the disruption of the 
interaction of a repressor called ZBED6 and results in three-fold upregulation of IGF2 mRNA 
expression in skeletal muscle with increase in muscle mass and meat production by 3-4%  
(Markljung et al., 2009). The upregulation of IGF2 occurs in postnatal muscle but not in the fetal 
muscle. The pigs carrying this mutant allele at the paternal chromosome of IGF2 showed higher 
expression in skeletal and cardiac muscles but not in the liver. Antisense non-coding transcript of 
IGF2 expression was also found to be regulated by the same mutation (Braunschweig et al., 
2004). This shows that repressor ZBED6 binding to its target sites in an unmethylated condition 
represses transcription of both IGF2 and IGF2-AS transcription. 
 
ZBED6 is the sixth mammalian protein with one or more BED domain. ZBED6 is derived from 
exapted DNA transposon that is encoded by an intron less gene located in the intron 1 of the 
zch311a gene. It contains an open reading frame of more than 900 codons, which is highly 
conserved among mammals (Markljung et al., 2009). It encodes a 110 kDa protein with distinct 
domain architecture. It contains two BED domains and a hATC dimerization domain. The BED 
domain was first identified in Drosophila protein BEAF and DREF that were used as the seed for 
the homology search using the bioinformatics analysis (Aravind; 2000). The hATC is from the 
hobo activator tam3. The two BED domains in ZBED6 are more closely related to each other than 
to any other mammalian BED domain. 
 
ZBED6 is highly conserved among the placental mammals and its DNA binding BED domain is 
almost 100% conserved among 26 mammalian species (Markljung et al., 2009). The predicted 
ZBED6 promoter showed that it has binding sites for transcription factors Max, Myc, Fos and NF-
E2, which are playing roles in cell proliferation and cancer development. The western blot 
analysis of ZBED6 showed two isoforms ZBED6a and ZBED6b. It was found that ZBED6 is 
residing in the nucleolus of myoblast C2C12 cells that also shows its importance in the process of 
cell growth and proliferation (Markljung et al., 2009; Mayer et al., 2005).  
 
ZBED6 was silenced in the C2C12 cells by using siRNA. The ZBED6-silenced and control cells 
were used to find the effect of silencing on the expression of specific gene. IGF2 mRNA 
expression was low on the first day in both control and silenced cells. On the other hand its 
expression on day 6 was increased in ZBED6-silenced cells as compared to control cells. The 
silencing of ZBED6 showed high levels IGF2 expression on day 6, increased cell proliferation on 
day 3 and wound healing on day3 which also confirms its role as repressor for IGF2 and its 
functional significance  (Markljung et al., 2009). 
 
The ChIP-sequencing experiment was carried out using the AB SOLiD technology. In this 
experiment the C2C12 mouse cells were used with anti-ZBED6 antibody to find the target genes 
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of ZBED6 other than IGF2. The results provided 24 million reads aligned to the mouse genome. 
2499 peaks were found with the minimum of 15 overlapping extended reads (Markljung et al., 
2009). ZBED6 peaks were often found in the near vicinity of transcription start sites TSS (with 
~50% located within 5kb) and about 28% ZBED6 binding sites were in CpG Island. It was seen 
the ZBED6 targets about 262 genes that encodes for transcription factors. Using de novo search 
on the ZBED6 binding fragments (full set and subset based on enrichment) shows that it has the 
consensus sequence of 5´ -GCTCGC- 3´which is a perfect match to the QTN region in IGF2. The 
annotated genes (~1200 genes) shows association with regulation of many biological processes, 
transcriptional regulation, neurogenesis, morphogenesis, cell signaling and muscle development.  
Some of the target genes of ZBED6 showed significant association with different diseases in 
human. These may include development disorders, cancer, cardiovascular disease, connective 
tissue disorders etc. (Markljung et al., 2009).  
 
Long non-coding RNAs 
The main idea that the transcription does have roles other than producing proteins mainly comes 
from the analysis of locus control regions LCR and enhancers. In some cases it was seen that the 
transcription of  LCR was needed to open the chromatin structure e.g. in case of Beta globin LCR, 
RNA polymerase II transcription opens the chromatin domains (Ashe et al., 1997; Gribnau et al., 
2000). 
 
The non-coding RNA genes are the DNA sequences that are transcribed but are not translated into 
protein. These include long non-coding RNAs and small non-coding RNAs which are abundantly 
transcribed in the mammalian genomes and are functionally important. The small non-coding 
RNAs include micro RNAs (miRNAs), small nucleolar RNAs (snoRNAs), small interfering 
RNAs (siRNAs), transfer RNA (tRNA), ribosomal RNAs (rRNAs) and piwi interacting RNAs 
(piRNAs). Many non-coding RNAs that interact with the general transcription factors are 
transcribed by RNA polymerase III. Other RNAs transcribed by RNA Polymerase III include 
tRNAs, snRNAs and 5S RNAs (Dieci et al., 2007). 
 
Long non-coding RNAs (lncRNAs) represent one class of extragenic non protein coding 
transcripts which results from the RNA polymerase II transcription of RNA genes (De Santa et 
al., 2010). Long non-coding RNAs have the size more than 200 nucleotides (Mercer et al., 2009). 
Few known examples include Xist, HOTAIR, Kcnq1ot1 etc. for which specific functions have 
been ascribed based on loss or gain of function experiments (Peny et al., 1996; Sleutels 2002; 
Mancini Dinardo et al., 2006). HOTAIR is the lncRNA that originate from the HOXC locus and 
have role in the epigenetic regulation. It represses the transcription across 40kb of the HOXD 
locus by changing the trimethylation state of chromatin (Rinn et al., 2007). Almost all the genes in 
the Kcnq1 locus are maternally expressed except for the kcnqot1 antisense lncRNA that is 
expressed paternally (Mitsuya et al., 1999). Xist which is another lncRNA is involved in the 
inactivation of X chromosomes in female placental mammals (Wutz et al., 2007). 
 
The lncRNAs generally lack the strong conservation which is often related to their evidence for 
non functionality (Struhl et al, 2007). But on the other hand the Xist and Air although poorly 
conserved RNAs show functional significance and suggest that there might be some different 
selection pressure (Nesterova et al., 2001; Pang et al., 2006). The lncRNAs show specific spatio 
temporal expression in mouse brain, T-cell differentiation and embryonic stem cell differentiation 
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(Mercer et al, 2008; Dinger et al., 2008; Pang et al., 2009). These lncRNAs have shown to have 
role in transcription regulation, post transcriptional processing and regulation of chromosomal 
architecture (Amaral et al., 2008; Mehler et al., 2006). They also have the ability to recruit the 
activators and repressors of chromatin that changes the epigenetic nature of chromatin for the 
protein coding genes in the vicinity (Mattick et al., 2009; Amaral et al., 2008).  
 
Different studies have shown the role of ncRNAs in diseases. In an expression analysis of tumor 
and normal cells, the change in expression of ncRNAs in different forms of cancer was observed. 
For example, ncRNA OCC1 (overexpressed in colon cancer) was overexpressed in colon 
carcinoma cells (Pibouin et al., 2002). PCGEMI another ncRNA was correlated with increased 
proliferation and cell growth regulation in the prostate tumor cells (Fu et al., 2006). In lung cancer 
the NEAT2 ncRNAs expression change was identified (Fu et., 2006). Similarly the mouse 
homologue of NEAT2 showed high expression in hepatocellular carcinoma (Lin et al., 2007).   
 
Transcription Factors and Biological Databases 
Gene regulation is largely regulated by proteins called transcription factors (TFs) that recognize 
cis-regulatory sequences present in the promoter and enhancer regions of genes. The process of 
gene expression in eukaryotic cells is a complex process in which transcription factors interact 
with regulatory cis-acting DNA sequences called transcription factor binding sites (TFBS). This 
DNA-protein interaction results in activation or repression of transcription. Specific cis-elements 
are often modular with multiple TFBS on a given target gene. One of the main goals of current 
biological research is to build the complete regulatory network of organisms (Covert et al., 2004). 
In a specific pathological process, the complete understanding of the transcriptional regulation 
might help in the discovery of new drug targets. Many transcription factors and their binding sites 
on target genes have been identified using in vitro techniques such as DNase I footprinting and 
electrophoretic mobility shift assay EMSA (Rooney et al., 1995). These processes are very time 
consuming and costly. In order to cope with this problem several computational algorithms and 
bioinformatics studies are used for the discovery of known or novel regulatory elements. In this 
case, the study of the regulatory regions of set of co-regulated genes is done. The algorithms are 
made to find the overrepresented motifs in the regulatory regions of co-regulated genes (Hertz et 
al., 1999; Hughes et al., 2000).  
 
Most transcription factors bind to short degenerative sequence motifs (6-12 bp) that frequently 
occur in the genome. This problem is solved by using computational approaches by modeling the 
transcription factor binding sites using the position weight matrix (PWM) to find the binding sites 
of transcription factors in the regulatory regions of gene sets. TRANSFAC is one of the databases 
commercially available that uses this approach (Matys et al., 2003). JASPAR (Sandelin et al., 
2004) is also a database for the transcription factors matrix and it is publically available. These 
computational methods are based on over representation of binding sites in the promoters of co 
expressed genes. This allows the development of regulatory network of genes by understanding 
the potential transcription factors involved in the regulation of gene expression. 
 
The aim of our study is to find the potential transcription factors that might be co-regulating the 
expression of number of genes with ZBED6, a novel transcription factor. The analysis will be 
done using the TRANSFAC database (professional version 2010.1). 
8 
 
MATERIALS AND METHODS 
 
Chromatin Immuno precipitation (ChIP) data (ZBED6 target genes) 
Chromatin Immuno Precipitation (ChIP) sequencing was done on mouse C2C12 myoblasts using 
the anti-ZBED6 antibody to identify targets of ZBED6 other than IGF2 (Markljung et al., 2009). 
As a result of which 2499 binding fragments (ZBED6 peaks) were found with a minimum of 15 
overlapping extended reads. The experiment was carried out using the AB SOLiD technology 
(Markljung et al., 2009). ZBED6 binding fragments from the ChIP data were used as the input set 
for bioinformatics analysis. We have used this input in TRANSFAC database version 2010.1, 
which is used for the prediction of transcription factor binding sites (TFBSs). Murine 
housekeeping genes (provided by TRANSFAC database version 2010.1 in ExPlain 3.0) were used 
as background or control set. We used the different sets of genes from the ChIP data as shown in 
Table 1A. The promoter window used was -1000 bp upstream and +1000 bp downstream to 
transcription start site (TSS).  
 
Microarray data (expression of ZBED6-silenced genes) 
Microarray expression analysis was done in mouse C2C12 cells using siRNA-silenced ZBED6 
and normal cells at day 2, day 4 and both day time points. In this case the genes that showed 
differential expression at day 2, day 4 and both time points (p value < 0.05) were used as the input 
set while the genes with no significant change in expression (p value > 0.05) were used as 
background set. The promoter window used was between -500 bp to 100bp downstream to TSS. 
The datasets used in MatchTM from the microarray data are shown in Table 1B. 
 
TRANSFAC 
TRANSFAC is a commercial database that is used to detect the transcription factors that might be 
responsible for the transcriptional regulation of the given gene sets. The data collection for 
TRANSFAC started more than 20 years ago to find the interaction of factors and DNA binding 
sites. Many improvements and modifications have been done over the years (Knüppel et al., 1994, 
Wingender et al., 1996). It is now part of the BIOBASE Knowledge Library (BKL) database 
(http://www.biobase-international.com/index.php?id=transfac). The analysis of TRANSFAC 
results is now done using ExPlain version 3.0, which is a component of BKL. Selected species 
covered by TRANSFAC include Homo sapiens, Canis lupus, Mus musculus (several strains), 
Rattus norvegicus, Gallus gallus, Saccharomyces cerevisiae (several strains).In order to find 
transcription factors that might be important in the co-regulation of ZBED6 targeted genes we 
used the TRANSFAC database professional version 2010.1 that is commercially available for 
finding the transcription factors in the promoter region of ZBED6 target genes (Markljung et al., 
2009). The professional version of TRANSFAC database provides access to large number of 
transcription factors, DNA and RNA binding sites, genes and matrices. The data for miRNAs 
ChIP-chip or ChIP-seq Fragments, promoter sequences of different species and references are 
only available in professional version of TRANSFAC. 
 
MatchTM 
The MatchTM is a web-based tool, designed for searching the potential transcription binding sites 
in the DNA sequences using the weight matrix search (Wingender et al., 2001). Match is 
9 
 
integrated in the TRANSFAC professional database and uses its positional weight matrices 
(PWM) for the analysis of given gene set. It provides the user with variety of search modes by 
optimizing the matrix cut off values. In TRANSFAC, each matrix available has pre calculated 
three different cut-offs (Pickert et al., 1998). 
• MinFP: minimum False Positive rate (over prediction error rate) 
• MinFN: min False Negative rate (under prediction error rate) 
• MinSUM: min SUM of both errors 
 
A number of tissue-specific profiles are also provided by the TRANSFAC database. In addition to 
several pre-defined profiles provided by TRANSFAC that are used in MatchTM, the user could 
create his own profiles with the Match Profiler tool. It also allows the user to have its own specific 
profile that can be selected as a set of matrices with default or user-defined cut off values. 
 
MatchTM takes DNA sequences or set of genes as an input and search for the potential TFBS 
using the PWM library (provided by TRANSFAC database). It searches for these binding sites 
within the promoter region of input genes. It gives the output in the form of list of potential TFBS 
and also the visual representation of their location in the sequences. 
The algorithm that is used at the back end for searching for the TFBS is based on two scoring 
values: 
• MSS: Matrix similarity score 
• CSS: Core similarity score 
These functions measure the quality of match (0.0 to 1.0 score) between the input sequence and 
the matrix, where 1.0 donates an exact match. The first five consecutive positions of matrix are 
conserved that are called the core of each matrix. The MSS is calculated using all positions of the 
matrix while the CSS is calculated using only the core positions. The cut off is the threshold that 
is used to match the matrix with the sequences. There are two cut offs used in MatchTM i.e. cut 
off for the matrix and cut off for core positions. The cut offs can be user-defined or default. If the 
CSS value is higher than the cut-off then it is accepted and added into the hash table and then it is 
extended at both the ends until it fits the matrix length. Then the MSS is checked and if it is 
higher than the cut-off it is given in the output table as the binding site for that factor that might be 
present in the sequence given (Kel et al., 2003). It is implemented in C language, which is 
wrapped by perl script to make it more user friendly (Kel et al., 1995). MatchTM is publicly 
available (http://www.gene-regulation.com/pub/programs.html#match). An advanced version of 
the tool called MatchTM Professional is available at (http://www.biobase.de). The professional 
version of MatchTM has access to professional TRANSFAC matrix library, which allows it to use 
large number of factors and matrices. 
 
By adding ZBED6 matrix into the vertebrate profile (having all transcription factor matrices for 
vertebrates) that was already present in TRANSFAC, a new profile was made called 
ZBED6_h0.01 profile. The cut off value used was MinSUM that minimize the error rate of both 
false positive and false negative prediction. 
 
Dataset used For MatchTM 
Two types of datasets were used in MatchTM Analysis. 
1. ChIP data (ZBED6 target genes) 
2. Microarray data (expression of ZBED6-silenced genes) 
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Table 1. Datasets from ChIP data and Microarray data subdivided into gene sets. A. ChIP data have 
the Hitlist (complete set of ZBED6-target genes), Upstream and downstream ZBED6 targets have all 
the genes having ZBED6 binding upstream or downstream to TSS, respectively.  Faraway target 
regions are the ones where ZBED6 binds with the distance from TSS greater than equal to 500kb. 
Highly enriched targets are those that show maximum overlapping reads in the ZBED6 peaks in ChIP 
results. B. Microarray data have the differentially expressed (DE) genes on day 2, day 4 and both days 
(ZBED6-silenced siRNA) with the p value < 0.05. 
SR.	   Data	  set	  used	  in	  MatchTM	   Genes	  used	   Total	  genes	  
1A.	   ChIP	  data	   	   	  1)	   Hitlist	  	  	  (All	  ZBED6	  target	  genes)	   1706	   2499	  2)	   Upstream	  ZBED6	  Targets	   657	   797	  3)	   Downstream	  ZBED6	  Targets	   1184	   1405	  3)	   Faraway	  target	  regions	   297	   297	  5)	   Highly	  Enriched	   889	   1000	  
1B.	   Microarray	  data	   	   	  
1)	   DE	  day	  2	  ZBED6-­‐silenced	  (P	  value	  <0.05)	   1600	   1600	  
2)	   DE	  day	  4	  ZBED6-­‐silenced	  (P	  value	  <0.05)	   1400	   1400	  
3)	   DE	  both	  day	  ZBED6-­‐silenced	  (P	  value	  <0.05)	   380	   380	  
 
Long Non-coding RNA 
Mammalian genomes show large amount of transcription that is occurring outside the mapped 
protein coding genes and generated large number of transcripts (Birney et al., 2007; Prasanth et 
al., 2007). Long non-coding RNAs lncRNAs represents one of the class of extragenic 
transcription products that results from RNA polymerase II transcription of RNA genes (De Santa 
et al., 2010).  
 
From the ChIP experiment that was carried out in the mouse C2C12 cells (Markljung et al., 2009), 
out of 2499 ZBED6 binding fragments we selected 300 regions that show the peaks at a distance 
of 500 kb away from known TSS. Long non-coding RNAs were obtained from two datasets i.e. 
Ponjavic dataset generated by FANTOM consortium and Guttman dataset of lncRNAs (Ponjavic 
et al., 2007; Guttman et al., 2009). These non-coding RNAs were further filtered out to eliminate 
all protein coding genes (Carninci et al., 2005). The Ponjavic dataset obtained was filtered against 
the Ensemble mouse protein coding genes annotations resulting in the dataset of 2168 lncRNAs 
and Guttman 1408 lncRNAs (De Santa et al., 2010). In order to find the overlapping lncRNAs 
with the ZBED6 binding sites we used the intersect option of “Operate on genomic intervals” in 
the web based tool galaxy browser available online (http://main.g2.bx.psu.edu/root).  
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Figure 2. Flowchart to find ZBED6 peak within 5 kb of TSS of long non-coding RNAs. 
 
We also used a perl script to find ZBED6 peaks within 5 kb of TSS of long non-coding RNA as in 
Figure 2. The script takes two files as an input. Here we give ZBED6 file with 300 regions 
(having 500 kb distance from TSS of known any known gene) and the second file is of non-
coding RNAs from Ponjavic and Guttman datasets. The Distance is calculated using the formula: 
  
Distance = Peak - TSS  Eq.1 
 
Peak in Eq.1 means binding site for ZBED6 and TSS is the transcription start site of long non-
coding RNA. If the distance is less than 5 kb then the non-coding RNA and ZBED6 is shown as 
an output. On the other hand if distance is greater than 5 kb it is rejected. In the end it produces an 
output file containing all accepted ZBED6 binding sits with predicted non coding RNA start and 
end site, the distance of ZBED6 from lncRNAs TSS and enrichment of ZBED6. The enrichment 
is the overlapping read that has been obtained for each ZBED6-binding site from ChIP sequencing 
(Markljung et al., 2009). 
YES 
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RESULTS 
 
ChIP Datasets 
 
Functional Analysis of ZBED6 
The TRANSFAC database analysis using ExPlain 3.0 on ZBED6 ChIP data from mouse C2C12 
cells revealed that ZBED6 target genes have significant role in different biological processes (Fig. 
3). The significant processes include developmental processes (e.g. nerves system development, 
embryonic development, organ development and anatomical structure development), gene 
expression, regulation of gene expression and metabolic processes etc. Highly enriched 
(maximum overlapping reads for ZBED6 binding sites) genes showed the role of target genes as 
developmental proteins (63 out of 756 genes). It also shows that most of the genes that have 
ZBED6 binding sites downstream to transcription start site TSS are involved in transcriptional 
regulation (151genes out of 1461 genes) and some are development proteins (87 out of 756). 
Whereas the genes with ZBED6 binding sites upstream to TSS are also activators (39 genes out of 
476 genes). 
 
 
Figure 3. Role of ZBED6 target genes in Biological processes 
 
Transcription factors in Promoter region of ZBED6 target gene  
MatchTM analysis was done on different sets of ZBED6 targets genes (see Materials and Methods 
ChIP data) in order to find the transcription factor binding sites in the promoter region of ZBED6 
target genes. The MatchTM results (transcription factors) were further filtered out using the 
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Yes/No >1.3 (Yes is the ZBED6 target gene set and No is the control set, here we used mouse 
house keeping genes as control) and p value < 0.001. The matrices for TFBSs that we obtained 
from MatchTM are shown in Figure 4.  
 
Figure 4. Matrices of transcription factors in ZBED6 target genes promoter. The transcription factors 
binding sites matrices using the MatchTM on ZBED6 target gene set. It gives the name of matrix, 
Yes/No where yes is the target gene set used and No is the mouse housekeeping gene set. The p- value 
shows the significant overrepresentation sites for the matrices found. The matched promoter p-value 
gives the significance for the binding sites found in the target gene set promoter. The filters used are 
yes/no >1.3, p-value <0.001 and matched promoter p-value <0.01. The table is sorted on basis of 
yes/no in descending order. The profile used was ZBED6h_0.01. The promoter window used is 
between -1000 to +1000 of TSS.  
 
Using different sets of ZBED6 target genes (Materials and Methods) we obtained the sets of 
transcription factors binding sites in promoter regions as shown in Table 2 and Figure 5 (Table 
S1). Using TRANSFAC database and MatchTM, putative common TFs are predicted in the 
majority of the genes targeted by ZBED6 (Fig. 6). These common TFs include AP2alpha, 
AP2gamma, ZF5, ZBED6, SP1, E2F1, EGR, CNOT3, ETF, HIC1, RNF96, CHCH and KROX. 
On the other hand there are few factors that are specific to target gene sets. For example, MTF1 
was seen in downstream ZBED6 target genes only while OLF1, NRSE, NFKappaB, LRF and 
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NGFIC were only seen in upstream targets of ZBED6. The gene set that was far away from TSS 
(i.e. 500 kb to TSS) showed that they have OCT1, NFAT, IRF1, DMRT2, and NANOG and even 
did not show some of the common factors (Fig. 6). 
 
Table 2. The Yes/No (ratio of ZBED6 target genes to background genes) values of transcription 
factors binding sites in the faraway, downstream, and upstream, top1000 and complete Hitlist of 
ZBED6 target gene sets. These gene sets are named with respect to the distance of ZBED6 binding site 
to TSS. 
Factors 
Farawway 
(yes/no) 
Downstream 
(yes/no) 
Upstream 
(yes/no) 
Top1000 
(yes/no) Hitlist (yes/no) 
ZF5 2.1389 5.0512 3.6087 5.3733 3.8884 
ZBED6 1.6027 3.5419 3.6995 2.0515 1.8628 
SP1 1.3354 2.2526 2.3176 1.6971 1.4701 
RNF96 3.6875 3.6226 4.7766 3.9323 2.9343 
KROX 0 4.2754 3.6314 3.9421 2.1739 
HIC1 0 2.1722 2.5575 2.8333 2.0274 
ETF 0 2.8075 2.798 2.6323 2.1904 
EGR 0 2.2793 1.9869 2.1167 1.4387 
E2F1 1.7119 2.9761 2.6375 2.69 2.21 
CNOT3 3.5429 3.2603 3.5017 2.8877 2.4815 
CHCH 0 2.155 2.1517 2.0727 1.5749 
AP2alpha 0 2.7254 2.4691 2.4 2.0067 
AP2gamma 0 2.6956 3.2054 4.17 2.0254 
OLF1 0 0 2.6725 0 1.8415 
NRSE 0 0 2.2489 2.0268 1.7508 
NGFIC 0 0 1.9065 0 1.6571 
NFKappaB 0 0 1.9996 0 0 
LRF 0 0 2.1625 2.0649 1.6768 
OCT1 1.4293 0 0 0 0 
NANOG 1.4 0 0 0 0 
NFAT 1.4843 0 0 0 0 
IRF 1.3265 0 0 0 0 
HNF1 1.4283 0 0 0 0 
HMGIY 1.4581 0 0 0 0 
FREAC2 1.78 0 0 0 0 
DMRT2 3.5851 0 0 0 0 
CDXA 1.7724 0 0 0 0 
BRN2 1.8617 0 0 0 0 
MTF1 0 2.4825 0 2.183 1.5812 
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Figure 5. Transcription factors of ZBED6 target genes graphical view. These are the factors that we 
get in different gene sets of ZBED6 using their yes to no values (Table 2). 
 
Figure 6. Common transcription factors in the gene set of ZBED6 targets. The figure shows that 
AP2alpha, AP2gamma, ZF5, ZBED6, SP1, E2F1, EGR, CNOT3, ETF, HIC1, RNF96, CHCH and 
KROX are the factors that have binding sites in the ZBED6-target genes. 
 
The TRANSFAC results suggest that most of these factors binds near the transcription start site as 
shown in the Figure 7 that clearly identifies the peak region for the binding of these factors to be 
close to TSS. This might suggest their role in the regulation of gene and it also supports the 
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previous result (ChIP sequencing results from Markljung et al., 2009) where most of the binding 
sites for ZBED6 lies close to TSS. 
 
 
Figure 7. Transcription factor binding sites more in the vicinity of TSS. The horizontal axis shows the 
promoter region with zero as the TSS. The vertical axis is the binding sites per sequence. 
 
Microarray Datasets 
 
Putative Transcription Factors in ZBED6-silenced Microarray data 
The TRANSFAC database analysis using ExPlain 3.0 on Microarray data from mouse C2C12 
cells after silencing of ZBED6 revealed that differentially expressed genes have significant role in 
different biological processes (Fig. 8). The developmental process is the most significant process 
including skeletal and striated muscle development, tissue, organ and system development. 
 
 
Figure 8. Role of ZBED6-silenced genes in Biological processes 
 
The results from MatchTM on microarray data suggest that SRF and MEF2 are most significantly 
expressed transcription factors in ZBED6-silenced C2C12 cells as shown in Figure 9. 
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Figure 9. Matrices of transcription factors in differentially expressed gene sets of ZBED6 silenced 
Microarray data. The promoter window used is between -500 to +100 of TSS. The Yes is the set of 
differentially expressed genes while No is the non-differentially expressed genes used as control set. 
The filters are applied to get the most significant matrices. 
 
The transcription factors that we obtained from TRANSFAC database MatchTM analysis shows 
that they are functionally important as shown in Table 3. 
 
Table 3. Transcription factors regulating ZBED6 target genes (selected factors). The table shows the 
factors with their functions and reference. 
Transcription Factor Name Function Reference 
AP2 Alpha 
(Activating protein alpha) 
Inhibits the growth of cells by 
inducing cell cycle arrest and 
apoptosis and crucial role in 
tumorigenesis 
Orso et al., 2008 
ZF5 
 
Transcriptional repressor in mouse c 
myc promoter 
Obata et al., 1999 
ZBED6 Repressor of IGF2 gene expression Markljung et al., 2009 
SP1 
(Sequence specific transcription 
factor 1) 
Required for expression of variety of 
genes involved in cell proliferation, 
apoptosis, development and 
differentiation.  
Kaczynski et al., 2003 
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E2F1 Crutial role in control of cell cycle 
and role as tumor suppressor protein. 
Tao et al., 1997 
OCT1 Octamer binding transcription factor 
(POU domain class 2 transcription 
factor) 
Marecki et al., 2001 
NFAT Nuclear factor of activated T cells 
mediated signal transduction 
pathways.Important in skeletal, 
cardiac muscle and nervous systems. 
Macian, 2005 
IRF1 (Interferon regulatory factor 1) Activates transcription of interferon 
alpha and beta. IRF1 plays role in 
regulating apoptosis and tumor 
suppression. 
Marecki el al., 2001 
 
HIC1 (hypermethylated in cancer 1) 
 
Gene encoding the zinc finger 
transcription factor belonging from 
the POZ family. It is also candidate 
tumor suppressor gene. Attenuates 
Wnt signaling 
Valenta et al., 2006 
  
Long Non-Coding RNA 
To find the long non-coding RNA that may be regulated by the ZBED6 we first find the distance 
of ZBED6 peak to the predicted long non-coding RNAs. In this case we have taken ZBED6-
binding fragments with 500 kb distance from the TSS. Out of 2499 binding fragments of ZBED6 
we obtained a set of 300 regions (Table S2). 
For the long non-coding RNAs we used two datasets Ponjavic dataset generated by FANTOM 
consortium and Guttman for the intergenic non-coding RNAs were further filtered out to 
eliminate the all protein coding genes (Carninci et al., 2005; Ponjavic et al., 2007; Guttman et al., 
2009). The obtained datasets Guttman and Ponjavic have 1408 and 2168 lncRNAs respectively 
(De Santa et al., 2010). Using the perl script (see Materials and Methods) we find the ZBED6 
peaks in the vicinity of lncRNAs TSS as shown in Table 4.  
 
Table 4. Shows the number of ZBED6 peaks with in the Range of long non-coding RNA Transcription 
start site.  
 Range  Guttman (1408) Ponjavic (2168) 
2kb 5 0 
5kb 8 0 
10kb 12 0 
20kb 13 1 
30kb 14 5 
40kb 14 6 
50kb 18 12 
60kb 23 14 
70kb 23 17 
80kb 27 21 
90kb 29 30 
100kb 35 39 
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Figure.10 Percentage of ZBED6 peaks near long non-coding RNAs TSS (Guttman and Ponjavic 
datasets).  
 
The graph (Fig. 10) shows that only about 2% of ZBED6 binding sites lies within 2 kb region of 
lncRNAs TSS. As the distance from the TSS increases the ZBED6 binding sites also increases 
(Table S3). This tells us that ZBED6 might not be present in the promoter region of non-coding 
RNAs but it could be present in the enhancer region of these non-coding RNA genes. Since the 
presence of ZBED6 at these regions could not be correlated with the protein coding genes, we can 
assume that maybe ZBED6 is playing the role of enhancer or silencer elements. 
 
Table 5. ZBED6 sites within 30 kb of lncRNAs.  
ZBED6 
Peak Chromosome Start_ncRNA End_ncRNA 
ZBED6 
Distance_TSS 
(30 kb) 
 
ZBED6 
Enrichment* 
 
mRNA_Genbank 
151643270 chr5 151621840 151622708 21430 26 AK029411  
48959270 chr14 48980247 48980948 -20977 24 AK007311  
143954645 chr3 143983177 143984712 -28532 20 AK035087  
143286560 chr3 143313273 143315051 -26713 16 AK034713  
95129690 chr10 95143442 95143758 -13752 16 AK009289  
* Enrichment is the overlapping reads obtained from ZBED6 ChIP data (Markljung et al., 2009)  
The mRNA from Gene bank (Table 5) for the non-coding RNAs, those have the ZBED6 peak 
present between 10 kb to 30 kb region. The genome view of one of the mRNA AK029411 is 
shown in Figure 11 A and B that is obtained by using UCSC and Ensemble browsers respectively. 
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Figure 11 B also shows presence of snoRNA genes like SNORA17 and few U3 (found 
predominantly in nucleolus), U4, U5 and U6 present in that region. These ncRNAs are seen in 
vicinity of few other mRNA also. 
 
A 
 
 
 
 
B. 
 
 
Figure 11. A. Long non coding mRNA AK029411 present at distance of 30 kb from ZBED6 peak using 
UCSC genome browser (http://genome.ucsc.edu/). B. The region around mRNA AK029411 shows 
some small nucleolar organizing RNAs snoRA1 , U3, U4, U5 and U6 using Ensembl genome browser 
(http://www.ensembl.org/Mus_musculus/Info/Index). 
 
DISCUSSION 
 
ChIP experiment 
The Chromatin Immuno precipitation ChIP experiment that was carried out in mouse C2C12 cells 
showed 2499 binding fragments for ZBED6. The experiment was carried out using the AB 
SOLiD technology (Markljung et al., 2009). ZBED6 binding fragments from the ChIP data were 
used as the input set for bioinformatics analysis using the TRANSFAC database and its MatchTM 
tool (professional version). The purpose of these bioinformatics analyses was to find the other TFs 
that might be co regulating the expression of genes with a novel transcription factor ZBED6. 
ZBED6 has shown to be involved in many biological processes including in developmental 
processes (e.g. nerves system development, embryonic development, organ development, 
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anatomical structure development etc.), gene expression, regulation of gene expression and 
metabolic processes (Fig. 3). Most of the genes that are downstream target of ZBED6 have role in 
transcriptional regulation. Where as few genes that are upstream target of ZBED6 show that they 
are activator proteins. This suggests the role of ZBED6 in transcription regulation and its 
involvement in many important developmental processes in mouse C2C12 cells. 
 
As the experiment was done in the mouse myoblast C2C12 cells we do not currently know much 
about its role in other cell types. However, ZBED6 is expressed in most cell types and is likely to 
have many more target genes. The CpG Island in IGF2 intron 3 was found to be non-methylated 
at a region centered at the QTN in case of skeletal muscle while in case of liver it was methylated 
(Van Laere at al., 2003). The epigenetic state of chromatin is therefore also very critical in the role 
of ZBED6. 
 
TRANSFAC: MatchTM 
In order to find the transcription factors binding sites TFBS in the ZBED6 targeted genes, we 
have used MatchTM tool that uses the position weight matrices provided by TRANSFAC library. 
A number of TFBSs were seen to be overrepresented in the promoter regions of ZBED6 target 
genes (Fig. 4). We have used promoter window of -1000 upstream to TSS and +1000 downstream 
to the TSS. A number of filters (p value < 0.001, yes/no >1.3) were also used to find the most 
significant transcription factors.  
The results of MatchTM can be biassed based on a number of reasons:  
• The gene sets (Material and Methods, ChIP datasets) that we have selected from the 
ZBED6 target list might have missed out some important genes.  
• The background or control set mouse house keeping genes that are provided by 
TRANSFAC database may have some genes missing. 
• There is a possibility that we might have missed out some important factors because of the 
filters that we have applied.  
• The gene expression is very complex process and it may or may not be same in different 
cell types. So the predicted transcription factors can be different or same in other scenario. 
• The transcription factors might not always bind to the fixed motif or TFBSs because there 
are other environmental and cellular components involved in the regulation of gene 
expression. This might affect the results that we obtain from the bioinformatics analysis. 
• Although the results were very much consistent with the previous results of ZBED6 
functional analysis and role in important biological processes but we cannot rule out the 
possibility of biasess due to the use of parameters and cut-off values. 
 
Transcription factors in ZBED6 target genes promoters  
The significant common transcription factors from the MatchTM analysis on ChIP data of ZBED6 
in mouse C2C12 cells are AP2alpha, AP2gamma, ZF5, ZBED6, SP1, E2F1, EGR, CNOT3, ETF, 
HIC1, RNF96, CHCH and KROX (Fig. 6 and Table 3). The majority of ZBED6-targeted genes 
show the binding sites for these transcription factors. This might suggest that ZBED6 along with 
these factors co regulates the expression of number of genes that are involved in many important 
biological processes. The results also revealed that majority of ZBED6 sites were closer to the 
ZF5 sites. In some cases the two binding sites were also overlapping.  
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On the other hand there are few factors that are specific to target gene sets. For example, MTF1 
was seen in downstream ZBED6 target genes only while OLF1, NRSE, NFKappaB, LRF and 
 
NGFIC were only seen in upstream targets of ZBED6. The gene set that was far away from TSS 
(i.e. 500 kb to TSS) showed that they have OCT1, NFAT, IRF1, DMRT2, and NANOG and even 
did not showed some of the common factors (Fig. 6). 
 
The TRANSFAC results suggests that most of these factors binds near the transcription start site 
as shown in the Figure 7 that clearly identifies the peak region for the binding of these factors to 
be close to TSS. This might suggest their role in the regulation of gene. It also supports the 
previous result (ChIP sequencing results from Markljung et al., 2009) where most of the binding 
sites for ZBED6 lies close to TSS. The transcription factors of Faraway gene set shows some 
contradiction to these binding sites in the vicinity of TSS.  
 
One important point to note here is the Faraway gene set (Materials and Methods, ChIP dataset) 
that have the ZBED6 binding sites at a distance of 500 kb way from TSS showed most of the 
factors that were not present in the other ZBED6 target gene sets (upstream or downstream). 
Furthermore, a few factors that are common to all sets are not present in this faraway set. One 
possibility is that these regions could be the enhancer regions for most of the genes present in the 
target list of ZBED6 and these factors may be enhancer elements. The other possibility is that 
these faraway regions are promoter regions of non-coding RNAs that are largely present in the 
intergenic regions of mammalian genomes (Birney et al., 2007; Prasanth et al., 2007). The 
hypothesis was further tested using the noncoding RNAs datasets and ZBED6 faraway regions. 
 
Long non-coding RNA 
The ChIP sequencing experiment using the C2C12 myoblast revealed more than 1200 of the 
ZBED6 binding sites that occurred within 5 kb of the TSS of an annotated gene (Markljung et al., 
2009). Using the gene ontology analysis it was revealed that these genes are associated with 
important biological processes including development, transcriptional regulation and cell 
differentiation. But those regions (300 out of 2499) that are at a distance of more than 500 kb 
from the known protein coding genes are still to be analyzed for their functional significance. The 
ZBED6 binding sites at this large distance from known TSS suggest that ZBED6 might have a 
regulatory role acting as a TF at enhancer or at distal promoter elements.  
 
The results of non-coding RNA (Fig. 10) shows that only 2% of ZBED6 sites in faraway regions 
lies within 2 kb of lncRNAs TSS. As the distance from the TSS of lncRNA increases the number 
of ZBED6 binding sites also increases. Table 5 shows some of the selected mRNA of these 
predicted non-coding RNAs having the ZBED6 binding sites at a distance of 30 kb away from 
TSS. Figure 11A and 11B shows that there are also small nuclear organizing RNAs in the vicinity 
of these lncRNAs. It is possible that ZBED6 has a functional role in regulating transcription of 
these small nucleolar organizing RNAs like snoRA17 and U3, U4 etc. U3 is a small nucleolar 
organizing RNA expressed predominantly in the nucleolus. This is an interesting possibility as we 
know that the localization of ZBED6 is also within nucleolus (Markljung et al., 2009). 
 
23 
 
Another possibility is that ZBED6 is not actually regulating transcription from promoter regions 
of these lncRNAs but instead by binding to enhancer regions. The other possibility is that these 
regions are the enhancer regions of many ZBED6 target genes (protein coding) and it remains to 
be established whether ZBED6 is functioning as an enhancer factor in those regions.  
We also cannot rule out the possibility that maybe it is present there due to the binding to the 
Histone H3K4me3/H3K36me3 chromatin signatures of characteristic active genes (Guttman et al., 
2009).  
 
Further experiments are needed to confirm these results to determine if there is really some 
functional significance of these intergenic (faraway) regions or whether they are artefactous hits 
from the ChIP experiments.  
 
Transcription factors in differentially expressed genes in ZBED6-silenced 
C2C12 cells 
In mouse myoblast C2C12 cells, ZBED6 was silenced using siRNA and the microarray analysis 
was done for day 2, day 4 and both days time point. The genes that showed the differential 
expression were analysed using TRANSFAC database. The functional analysis (Fig. 8) showed 
that majority of genes that are potentially regulated by ZBED6 have role in the development of 
skeletal muscle, tissues and organs. The results (Fig. 9) showed that SRF and MEF2 in all cases 
were common transcription factors in these gene sets while in some cases Myogenin, MYOD, 
LYF and MAZ (muscle specific) transcription factors were also seen. SRF and MEF2 have role in 
muscle development. The factors that were found on day 2 have more role in cell cycle and 
proliferation of cells. While the factors that were found for both day time points showed that they 
are more involved in the process of differentiation of cells. This result also supports the role of 
IGF2 in muscle development (Florini et al., 1991). The role of ZBED6 as repressor was first of all 
identified in the IGF2 gene at the QTN region (Van Laere et al., 2003). However, based on 
available microarray results following ZBED6-silencing it should be stressed that ZBED6 may 
function not only as a repressor but also as an activator of transcription for a number of genes in 
C2C12 cells. The functional role of ZBED6 as a transcriptional regulator of other genes besides 
IGF2 remains to be established. Furthermore, target genes for ZBED6 in other cells types will be 
determined and the role of ZBED6 in other cell types except myoblasts needs to be determined.  
 
Our current proposed model for ZBED6 function as repressor or activator is summarized in Figure 
12. The IGF2 locus indicates that ZBED6 acts primarily as a repressor but there is a possibility 
that it acts as activator under certain circumstances.  
 
The repressor model shows the binding sites of the transcription factors AP2, HIC1, MEF2, SP1 
and ZBED6 in the promoter region (-500 bp to +500 bp from TSS) of the upregulated genes in 
ZBED6 silenced C2C12 cells. These transcription factors have crutial role in the cell cycle arrest 
and tumorigenesis (Table 3). MEF2 which is Myocyte enhancer factor 2 controls the muscle 
specific and growth factor inducible genes. HIC1 is epigenetically inactivated in cancer and 
encodes the zinc finger transcription factor belonging to the POZ family. It is also a candidate 
tumor suppressor gene. ZBED6 along with these transcription factors may repress the expression 
of number of genes involved in the tumorigenesis. There is a need to confirm this using functional 
biological experiments as the presence of binding sites may not be the proof of regulation of 
expression. 
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The activator model shows the binding sites of the transcription factors E2F1, ZF5, SP1,KROX, 
OCT1, IRF1 and ZBED6 in the promoter region of downregulated genes under ZBED6 silenced 
C2C12 cells. It is observed that ZF5 (ZiN POZ domain contain transcription factor) sites were 
overlapping with the ZBED6 binding sites for the majority of genes and SP1 and KROX binding 
sites were also in the close proximity. IRF1 and OCT1 were observed together in a number of 
genes. All these transcription factors have GC rich binding sites and the majority belong to the 
family of zinc finger transcription factors. There is a possibility that ZBED6 along with other zinc 
finger transcription factors coregulates the expression of genes involved in important biological 
processes.  
 
A 
 
B 
 
Figure 12 A. Proposed ZBED6 repressor model. TFBS in the promoter region of Upregulated gene set 
in siRNA silenced ZBED6 C2C12 cells. B. Proposed ZBED6 activator model. TFBS in the promoter 
region of Down regulated gene set in siRNA silenced ZBED6 C2C12 cells. 
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CONCLUSION  
 
The ZBED6 factor along with a number of transcription factors (e.g. HIC1, AP2alpha, ZF5, E2F1, 
KROX, SP1 majority belonging from zinc finger family and having GC rich binding sites) co-
regulates the expression of genes that have roles in important biological processes (proliferation, 
differentiation and development). The majority of factors found in the promoter regions of 
ZBED6 target genes show that they are involved in tumor suppression. This suggests that ZBED6 
might be involved in the suppression of tumorigenesis a notion supported by the fact that many of 
the identified ZBED6 target genes have established roles as tumor suppressors. In the absence of 
ZBED6 the transcription factors like SRF and MEF2 are involved in the cell differentiation and 
muscle development.  
 
ZBED6 also show some enhancer activity with the transcription factors OCT1, IRF1 and NFAT. 
These factors might together with ZBED6 be co-regulating the expression of number of genes. 
ZBED6 might be present in the enhancer region of long non-coding RNAs and regulating their 
expression. These ncRNAs does have roles in the different types of carcinomas. ZBED6 might be 
regulating their expression as well. 
 
FUTURE PROSPECTS 
In future the significance of these transcription factors can be confirmed by looking into the 
evolutionary conserved ZBED6 target genes. There is also a need to confirm the co-regulation of 
these factors biologically by performing functional experiments as the bioinformatics analysis 
only provides a prediction that needs to be experimentally confirmed. For the correlation of long 
non-coding RNAs with ZBED6 the complete set of lncRNAs including known and unknown 
should be taken into consideration to conclude the study. This may be possible as more lncRNAs 
become described as a result of global transcriptome experiments. 
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